Addressing COVID-19 Screening Delays: The Impact of HPV Self-Sampling on Non-Attenders in a Cervical CancerScreening Program

A. Chiereghin et al.

Source

Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen)

Anita W. W. Lim et al.

Source

Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs

Michele Qi et al.

Source

Acceptance of Self-Sampling and Knowledge about Human Papillomavirus among Women in Mongolia

Tsetsegsaikhan Batmunkh et al.

Source

Copan MSwab® maintains HPV nucleic acid stability after long term storage

Stefania Di Costanzo, Simone Paghera, Michele Rosso, Cristiano Sabelli

Copan MSwab® maintains HPV nucleic acid stability at challenging temperatures

Stefania Di Costanzo, Simone Paghera, Michele Rosso, Cristiano Sabelli

Copan Self Vaginal FLOQSwabs®:Agreement between clinician and self-collected samples for HPV detection. Evidence from the scientific literature

Stefania Di Costanzo, Cristiano Sabelli.

Performance evaluation of a self-administered point-of-care test for anal HPV screening in PrEP users: data from a community-based PrEP service

Lorenzo Biasioli et al.

Source

Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples

Marianna Martinelli et al.

Source

Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial

Rachel L. Winer et al.

Source

Preliminary Results of Feasibility and Acceptability ofSelf-Collection for Cervical Screening in Italian Women

Illari Sechi et al.

Source

Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer:implementation studies from five sub-Saharan African countries

Jessica Joseph et al.

Source

Age-specific and genotype-specific carcinogenic human papilloma virus prevalence in a country with a high cervical cancer burden: results of across-sectional study in Estonia

Kersti Pärna et al.

Source

Genotype heterogeneity of high-risk human papillomavirus infection in Ethiopia

Ayichew Seyoum  et al.

Source

Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study

Marianna Martinelli et al.

Source

Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program

Su Pei Khoo et al.

Source

Effect of the environment on home-based self-sampling kits for anal cancer screening

Jenna Nitkowski et al.

Source

Self-Collection for Under-Screened Women in a National Cervical Screening Program: Pilot Study

M. Saville

Source

Assessing the Impact of Mailing Self-Sampling Kits for Human Papillomavirus Testing to Unscreened Non-Responder Women in Manitoba

F. Jalili

Source